Many patients wonder whether they need to see a primary care provider, endocrinologist, or weight-loss specialist before discussing prescription weight-management medication.
We're celebrating the Wholesome Clinic Frisco Grand Opening on Saturday, November 7, 2026. Meet our team, tour the clinic and learn more about our integrated psychiatric, weight-management and wellness services.
Psychiatrists are physicians who diagnose and treat mental health conditions. Their prescribing authority is not limited only to antidepressants, anxiety medications, or other psychiatric drugs.
Weight management is not a routine part of every psychiatry practice. A psychiatrist should have the appropriate knowledge, clinical systems, and monitoring processes before providing prescription weight-management care.
For some patients, however, mental health and weight concerns overlap. Depression may affect sleep, appetite, motivation, and physical activity. Certain psychiatric medications can also contribute to weight changes.
In these situations, a clinician who understands both mental and physical health can consider the complete clinical picture rather than treating each concern as completely separate.
Potentially, yes. A psychiatrist who is appropriately licensed and practicing within applicable laws and clinical standards may prescribe GLP-1 or related weight-management medications when medically appropriate.
Two active ingredients patients commonly hear about are semaglutide and tirzepatide. The specific brand matters because medications containing the same active ingredient can have different FDA-approved uses.
Yes, a psychiatrist may prescribe Wegovy (semaglutide) when the clinician determines that it is medically appropriate and prescribing it is consistent with applicable professional and legal requirements.
Wegovy is an FDA-approved prescription medication used for chronic weight management in certain patients.
A psychiatrist may prescribe Zepbound (tirzepatide) when appropriate. Zepbound has FDA-approved weight-management indications for eligible patients.
Medical eligibility does not automatically mean Zepbound is the best treatment for a particular patient.
Ozempic and Wegovy both contain semaglutide, but they have different FDA-approved indications.
Ozempic is primarily approved for specific indications involving type 2 diabetes and related health risks. Prescribing a medication for a use outside its FDA-approved labeling is called off-label prescribing.
Potentially. Phentermine is a Schedule IV controlled substance and requires additional clinical consideration.
Factors such as blood pressure, cardiovascular health, anxiety, sleep, current medications, substance-use history, and other medical conditions may affect whether it is appropriate.
Mounjaro contains tirzepatide, the same active ingredient found in Zepbound, but the two medications have different FDA-approved indications.
Mounjaro is used for specific indications involving type 2 diabetes, while Zepbound has FDA-approved weight-management indications.
Prescription weight management should begin with an appropriate medical evaluation. Depending on the medication and the individual patient, that evaluation may include:
This is one area where psychiatric and weight-management care can overlap. Some medications used for mental health conditions can affect appetite, metabolism, or body weight.
Your clinician may evaluate whether a medication is contributing to weight changes, whether another psychiatric treatment may be reasonable, or whether weight-management strategies should become part of your care plan.
Sometimes the best answer is not adding another medication. Treatment should support both mental health stability and physical health.
Yes. Prescription medication is only one possible part of weight management.
Mental health can influence sleep, motivation, emotional eating, stress, appetite, and a person's relationship with food.
For some patients, treatment may include addressing depression, anxiety, binge-eating symptoms, sleep problems, or medication-related weight changes alongside nutrition, activity, and medical care.
Other patients may benefit from coordinated care with a primary-care clinician, obesity-medicine specialist, endocrinologist, dietitian, therapist, or another healthcare professional.
No. Compounded medications are not the same as FDA-approved brand-name products.
Compounded medications do not undergo the same FDA premarket review for safety, effectiveness, and quality as FDA-approved finished drug products.
Patients should know:
A psychiatrist does not need to manage every aspect of a patient's weight. Referral or coordinated care may be more appropriate when a patient has complex medical conditions.
Examples may include poorly controlled diabetes, significant cardiovascular disease, endocrine concerns, severe obesity-related complications, or another medical problem requiring specialized management.
Yes. Psychiatrists are physicians and may prescribe weight-loss medications when doing so is medically appropriate and consistent with applicable laws, professional standards, and their clinical practice.
Potentially, yes. A psychiatrist may prescribe GLP-1 or related medications when appropriately qualified to manage treatment and when the medication is clinically appropriate for the patient.
Potentially. Wegovy has FDA-approved weight-management indications. Whether it is appropriate depends on your medical history, medications, risks, and other clinical factors.
Potentially. Zepbound has FDA-approved weight-management indications for eligible patients. Your clinician must determine whether it is medically appropriate for you.
A psychiatrist may have authority to prescribe Ozempic, but Ozempic and Wegovy have different FDA-approved indications even though both contain semaglutide. Off-label prescribing requires an individualized clinical decision.
Potentially. Phentermine is a Schedule IV controlled substance, so additional clinical, safety, state, and federal prescribing requirements may apply.
Potentially. The answer depends on state scope-of-practice and prescribing laws, the clinician's training and competence, any collaborative or supervisory requirements, and the medication involved.
Yes. A psychiatric clinician can evaluate whether a medication may be contributing to weight changes and discuss possible treatment strategies. Do not stop or change a psychiatric medication without speaking with your clinician.
Stephanie Ukoha provides psychiatric and medical weight-management evaluations through Wholesome Clinic. Her dual certification in family and psychiatric care supports a whole-person approach when mental health, psychiatric medications, appetite, metabolic health, and weight-related concerns overlap.
Treatment recommendations are individualized after review of medical history, current medications, laboratory results when appropriate, mental health history, treatment goals, and relevant safety considerations.
Mental and physical health do not always occur as separate issues. Depression, anxiety, sleep problems, psychiatric medications, appetite, metabolic health, and weight concerns can overlap.
Wholesome Clinic provides psychiatric care and medical weight-management services, allowing eligible patients to receive a more integrated assessment when these concerns occur together.
Our Frisco clinic provides in-person care, with telehealth services available where offered.
Schedule a medical weight loss evaluation or explore the treatment options available through Wholesome Clinic. Your clinician can review your health history, medications, goals, and safety considerations and help determine what treatment pathway may be appropriate.
For additional information about prescription medications used for chronic weight management, visit the U.S. Food and Drug Administration and the National Institute of Diabetes and Digestive and Kidney Diseases .
